Sim&Cure and Siemens Healthineers partner to advance brain aneurysm treatment

A recent press release from the two companies notes that “immediate medical intervention is crucial for ruptured aneurysms”, while “proactive management of unruptured aneurysms can prevent future health crises”. The release also states that detection and treatment of brain aneurysms remain critical to preventing potential ruptures and associated health issues.

As such, their partnership will attempt to bring together the expertise and technology leadership of both companies to create and promote innovative solutions designed to improve the precision and effectiveness of brain aneurysm interventions. By combining Sim&Cure’s cutting-edge simulation technology with Siemens Healthineers’ advanced imaging systems, the collaboration will offer healthcare professionals state-of-the-art tools to enhance diagnosis, treatment planning, and patient outcomes, the release adds.

Both companies are committed to maintaining the highest standards of quality and compliance, the release continues, and—through coordinated efforts—will demonstrate the significant benefits of their solutions for brain aneurysm treatment. Their common activities will be led jointly, ensuring consistency and alignment with each company’s brand and regulatory requirements. This collaborative approach will help to effectively communicate the advantages of the combined technologies to healthcare providers worldwide.

This collaboration is driven by a “shared vision” to improve patient care by advancing the tools available for brain aneurysm treatment, and “not only represents a significant step forward in the current capabilities of brain aneurysm treatment but also sets the stage for future innovations”, the release details.

“We are thrilled to partner with Siemens Healthineers—a company that shares our dedication to improving patient outcomes through innovation,” said Mathieu Sanchez, chief executive officer and co-founder of Sim&Cure. “This collaboration allows us to combine our expertise in numerical modelling with Siemens Healthineers’ unparalleled imaging technology, creating a powerful synergy that will benefit both healthcare providers and patients.”

“Instilling greater clinical confidence by delivering high performance and value to our customers is at the core of everything we do,” added Jayant Saha, head of global business development, Interventional Radiology, Advanced Therapies, Siemens Healthineers. “Simulation in neurovascular aneurysm treatment is proving to be an important and growing, indispensable tool in interventional neuroradiology. Siemens Healthineers and Sim&Cure hereby look forward to offering cutting-edge technological advances in the field of neurovascular aneurysm treatment to our joint customers and the patients they care for.”